Could be applying for tissue agnostic as well. All they can do is say ok for GBM but for all tissue it is a “NO” or a “YES” with combination studies.
How could it take even these people this long after DL if it was not for more? Just my take. The Italian paper indicated pretty much that path if only for GBM. Doubt any useful information will appear in the 10q.
Market Data 
Markets 
AI
